Ilse Van Brussel

678 total citations
19 papers, 536 citations indexed

About

Ilse Van Brussel is a scholar working on Immunology, Immunology and Allergy and Molecular Biology. According to data from OpenAlex, Ilse Van Brussel has authored 19 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 6 papers in Immunology and Allergy and 3 papers in Molecular Biology. Recurrent topics in Ilse Van Brussel's work include Immunotherapy and Immune Responses (8 papers), Atherosclerosis and Cardiovascular Diseases (8 papers) and T-cell and B-cell Immunology (7 papers). Ilse Van Brussel is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Atherosclerosis and Cardiovascular Diseases (8 papers) and T-cell and B-cell Immunology (7 papers). Ilse Van Brussel collaborates with scholars based in Belgium, Australia and Poland. Ilse Van Brussel's co-authors include D. Schrijvers, Hidde Bult, Emily A. Van Vré, Christiaan Vrints, Johan Bosmans, Nathalie Cools, Guido R.Y. De Meyer, Jorrit De Waele, Yannick Willemen and Eva Lion and has published in prestigious journals such as Gastroenterology, PLoS ONE and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Ilse Van Brussel

19 papers receiving 533 citations

Peers

Countries citing papers authored by Ilse Van Brussel

Since Specialization

Citations

This map shows the geographic impact of Ilse Van Brussel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilse Van Brussel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilse Van Brussel more than expected).

Fields of papers citing papers by Ilse Van Brussel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilse Van Brussel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilse Van Brussel. The network helps show where Ilse Van Brussel may publish in the future.

Co-authorship network of co-authors of Ilse Van Brussel

This figure shows the co-authorship network connecting the top 25 collaborators of Ilse Van Brussel. A scholar is included among the top collaborators of Ilse Van Brussel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilse Van Brussel. Ilse Van Brussel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	The tele-transition of toxicity management in routine oncology care during the severe acute respiratory syndrome (SARS-CoV-2) pandemic 2021 ·British Journal of Cancer ·Marika Rasschaert, (unknown), (unknown), Ella Roelant, (unknown), Hans Prenen, Anke Verlinden, Ilse Van Brussel, (unknown), Annelies Janssens, Peter A. van Dam, Marc Peeters	3
2	AMTRA: a multicentered experience of a web-based monitoring and tailored toxicity management system for cancer patients 2020 ·Supportive Care in Cancer ·Marika Rasschaert, Christof Vulsteke, (unknown), (unknown), (unknown), Vincent Verschaeve, Peter Vuylsteke, Ilse Van Brussel, (unknown), Peter A. van Dam, Eva Segelov, Marc Peeters	16
3	Long-Term Depletion of Conventional Dendritic Cells Cannot Be Maintained in an Atherosclerotic Zbtb46-DTR Mouse Model 2017 ·PLoS ONE ·Miche Rombouts, Nathalie Cools, Mandy O. J. Grootaert, (unknown), Ilse Van Brussel, An Wouters, Guido R.Y. De Meyer, Benedicte Y. De Winter, D. Schrijvers	9
4	Feasibility of an interactive electronic self-report tool for oral cancer therapy in an outpatient setting 2016 ·Supportive Care in Cancer ·Marika Rasschaert, (unknown), Christian Rolfo, Ilse Van Brussel, (unknown), Marc Peeters	8
5	Linking CD11b⁺Dendritic Cells and Natural Killer T Cells to Plaque Inflammation in Atherosclerosis 2016 ·Mediators of Inflammation ·Miche Rombouts, (unknown), Ilse Van Brussel, Lynn Roth, Benedicte Y. De Winter, Sven R. Vercauteren, Jeroen Hendriks, Patrick Lauwers, Paul E. Van Schil, Guido R.Y. De Meyer, Erik Fransén, Nathalie Cools, D. Schrijvers	23
6	Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs 2014 ·Pharmacology & Therapeutics ·(unknown), Jorrit De Waele, Yannick Willemen, Ilse Van Brussel, D. Schrijvers, Eva Lion, Evelien Smits	140
7	Impaired gait pattern as a sensitive tool to assess hypoxic brain damage in a novel mouse model of atherosclerotic plaque rupture 2014 ·Physiology & Behavior ·Lynn Roth, Debby Van Dam, Carole Van der Donckt, D. Schrijvers, Katrien Lemmens, Ilse Van Brussel, Peter Paul De Deyn, Wim Martinet, Guido R.Y. De Meyer	15
8	Fluorescent activated cell sorting: An effective approach to study dendritic cell subsets in human atherosclerotic plaques 2014 ·Journal of Immunological Methods ·Ilse Van Brussel, (unknown), Miche Rombouts, Nathalie Cools, Sven R. Vercauteren, (unknown), Jeroen Hendriks, Patrick Lauwers, Paul E. Van Schil, D. Schrijvers	16
9	Mo1703 Schistosoma Mansoni Helminth Egg Antigens (SEA) and Their Protective Effect on Colitis in a Murine Transfer Model 2014 ·Gastroenterology ·(unknown), Nathalie E. Ruyssers, Sara Nullens, Joris G. De Man, D. Schrijvers, Ilse Van Brussel, Gabriele Schramm, Paul Pelckmans, Tom G. Moreels, Benedicte Y. De Winter	1
10	Tolerogenic dendritic cell vaccines to treat autoimmune diseases: Can the unattainable dream turn into reality? 2013 ·Autoimmunity Reviews ·Ilse Van Brussel, (unknown), Miche Rombouts, (unknown), (unknown), Benedicte Y. De Winter, Nathalie Cools, D. Schrijvers	73
11	Potential Use of Dendritic Cells for Anti-Atherosclerotic Therapy 2013 ·Current Pharmaceutical Design ·Ilse Van Brussel, D. Schrijvers, Emily A. Van Vré, Hidde Bult	8
12	Transcript and Protein Analysis Reveals Better Survival Skills of Monocyte-Derived Dendritic Cells Compared to Monocytes during Oxidative Stress 2012 ·PLoS ONE ·Ilse Van Brussel, D. Schrijvers, Wim Martinet, Isabel Pintelon, (unknown), (unknown), Louis Maes, Johan Bosmans, Christiaan Vrints, Dirk Adriaensen, Paul Cos, Hidde Bult	9
13	Optimizing Dendritic Cell-Based Immunotherapy: Tackling the Complexity of Different Arms of the Immune System 2012 ·Mediators of Inflammation ·Ilse Van Brussel, Zwi Berneman, Nathalie Cools	35
14	Everolimus Triggers Cytokine Release by Macrophages 2012 ·Arteriosclerosis Thrombosis and Vascular Biology ·Wim Martinet, Stefan Verheye, Inge De Meyer, Jean‐Pierre Timmermans, D. Schrijvers, Ilse Van Brussel, Hidde Bult, Guido R.Y. De Meyer	27
15	Immunohistochemical characterisation of dendritic cells in human atherosclerotic lesions: possible pitfalls 2011 ·Pathology ·Emily A. Van Vré, Johan Bosmans, Ilse Van Brussel, Mieke Maris, Guido R.Y. De Meyer, Paul E. Van Schil, Christiaan Vrints, Hidde Bult	27
16	Dendritic Cells in Human Atherosclerosis: From Circulation to Atherosclerotic Plaques 2011 ·Mediators of Inflammation ·Emily A. Van Vré, Ilse Van Brussel, Johan Bosmans, Christiaan Vrints, Hidde Bult	48
17	Decreased numbers of peripheral blood dendritic cells in patients with coronary artery disease are associated with diminished plasma Flt3 ligand levels and impaired plasmacytoid dendritic cell function 2011 ·Clinical Science ·Ilse Van Brussel, Emily A. Van Vré, Guido R.Y. De Meyer, Christiaan Vrints, Johan Bosmans, Hidde Bult	34
18	Changes in blood dendritic cell counts in relation to type of coronary artery disease and brachial endothelial cell function 2010 ·Coronary Artery Disease ·Emily A. Van Vré, Ilse Van Brussel, Ken Op de Beeck, Vicky Y. Hoymans, Christiaan Vrints, Hidde Bult, Johan Bosmans	27
19	Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood 2010 ·Journal of Immunological Methods ·Ilse Van Brussel, Emily A. Van Vré, Guido R.Y. De Meyer, Christiaan Vrints, Johan Bosmans, Hidde Bult	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact